Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

rs2431697, a Polymorphism of Mir-146a, Is a Precozing Marker of Progression to Secondary Myelofibrosis: New Epigenetic Regulation of Jak/Stat3 Signaling

Blood (2018) 132 (Supplement 1): 3072.

https://doi.org/10.1182/blood-2018-99-119221

Published: 2018

Journal Articles

H3K27M/I Mutations Promote Context-Dependent Transformation in Acute Myeloid Leukemia with RUNX1 Alterations

Bernhard Lehnertz, PhD, Yu Wei Zhang, Isabel Boivin, Nadine Mayotte, Tomellini Elisa, PhD, Jalila Chagraoui, PhD, Vincent-Philippe Lavallée, MD, Josée Hébert, MD, Guy Sauvageau, MD, PhD

Blood (2017) 130 (Supplement 1): 302.

https://doi.org/10.1182/blood.V130.Suppl_1.302.302

Published: 2017

Journal Articles

Improving Hospice Referral: Application of Regret-Based Decision Modeling at End-of-Life Care

Benjamin Djulbegovic, MD PhD, Athanasios Tsalatsanis, PhD, Rahul Mhaskar, MPH, PhD, Iztok Hozo, PhD, Branko Miladinovic, PhD, Howard Tuch, MD PhD

Blood (2016) 128 (22): 535.

https://doi.org/10.1182/blood.V128.22.535.535

Published: 2016

Journal Articles

Gene Expression Profiling of Extramedullary Disease-Related Toward Identification of a Terminal Disease Pathway in Multiple Myeloma

Sarah Waheed, MD, Hongwei Wang, Pingping Qu, PhD, Christoph Heuck, MD, Aasiya Matin, Yogesh Jethava, MB, MRCP, MD FRCPath, Frits van Rhee, MD PhD, Antje Hoering, Bart Barlogie, MD PhD, Faith E Davies, MD, Gareth J Morgan, MDPhD

Blood (2015) 126 (23): 1777.

https://doi.org/10.1182/blood.V126.23.1777.1777

Published: 2015

Journal Articles

A Targeted Functional Clone Tracking Assay for the Identification of Tumour Suppressor Genes in BCP- ALL Implicates the Transcription Factors FOXO3 and PRDM1

Paul Sinclair, PhD, Joanna Cheng, Prahlad Raninga, Rebecca Hanna, Shaun Hollern, Amir Enshaei, PhD, Helen Blair, PhD, Sirintra Nakjang, Sarra Ryan, PhD, Jeyanthy Eswaran, PhD, Lars Buechler, Olaf Heidenreich, PhD, Christine Harrison, PhDFRCPath FMedSci

Blood (2015) 126 (23): 2449.

https://doi.org/10.1182/blood.V126.23.2449.2449

Published: 2015

Journal Articles

Prolonged Overall Survival with Pomalidomide and Dexamethasone in Myeloma Characterized with End Stage Disease.

Blood (2012) 120 (21): 2961.

https://doi.org/10.1182/blood.V120.21.2961.2961

Published: 2012

Journal Articles

Patterns of CNS Involvement in Relapsed and/or Refractory Multiple Myeloma.

Al-Ola Abdallah, MD, Shebli Atrash, MD, Jameel Muzaffar, MD, Nisar Ahmad, MD, Sajjad Haider, MD, Monica Grazziutti, MD, Senu Apewokin, MD, Zainab Shahid, MD, Alejandro Restrepo, MD, Sarah Waheed, MD, Frits van Rhee, MD, PhD, Bart Barlogie, MD, PhD, Saad Z Usmani, MD FACP

Blood (2012) 120 (21): 2925.

https://doi.org/10.1182/blood.V120.21.2925.2925

Published: 2012

Journal Articles

Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Refractory Patient-Derived Multiple Myeloma Cells, Growing in a Novel Humanized Mouse MM Model

Willy A Noort, PhD, Richard W.J. Groen, PhD, Reinier Raymakers, MD, PhD, Linda Aalders, Frans M Hofhuis, Berris Van Kessel, Jeroen F Van Velzen, Joost de Bruijn, PhD, Huipin Yuan, PhD, Jeroen Lammerts van Bueren, PhD, Andries C Bloem, PhD, Paul W.H.I. Parren, PhD, Henk Lokhorst, MD, Tuna Mutis, MD PhD, Anton C.M. Martens, PhD

Blood (2012) 120 (21): 940.

https://doi.org/10.1182/blood.V120.21.940.940

Published: 2012

Journal Articles

Virus-Associated Hemophagocytic Syndrome Contributes to Fatal Outcome In Critical Ill Patients with 2009 Influenza A (H1N1) Infection.

Gernot Beutel, Olaf Wiesner, Matthias Eder, Jan T. Kielstein, Carsten Hafer, Andrea S. Schneider, Tina Ganzenmueller, Christian Kuehn, Axel Haverich, Albert Heim, Tobias Welte, Marius M. Hoeper, Arnold Ganser, MD

Blood (2010) 116 (21): 3795.

https://doi.org/10.1182/blood.V116.21.3795.3795

Published: 2010

Journal Articles

Loss of Chemokine Receptor Expression and Tetraspanins Is Correlated with Extramedullary Disease In Multiple Myeloma

Zeba N Singh, MD, Rebecca B Owens, BSMT, Bijay Nair, MD, MPH, John Shaughnessy, Jr., PhD, Bart Barlogie, MD, PhD

Blood (2010) 116 (21): 2983.

https://doi.org/10.1182/blood.V116.21.2983.2983

Published: 2010

Journal Articles

Only Concomitant Presence of Cytogenetic Abnormalities in Randomly Sampled Bone Marrow and in MRI-Defined Focal Lesions Imparts Poor Prognosis and Is Associated with Gene Expression Profiling (GEP)-Based High-Risk Myeloma.

Bijay Nair, PhD, Yiming Zhou, PhD, Bart Barlogie, MD, PhD, Jeffrey Sawyer, PhD, Jackie Szymonifka, John Crowley, PhD, John D. Shaughnessy, Jr., PhD

Blood (2008) 112 (11): 1691.

https://doi.org/10.1182/blood.V112.11.1691.1691

Published: 2008

Journal Articles

Preclinical Studies Using Polyethylenimine (PEI) Nanoparticles Complexed with Eukaryotic Translation Initiation Factor 5A (eIF5A) siRNA and eIF5A K50R Plasmid DNA Demonstrates Significant Anti-Myeloma Activity in Vitro and in Vivo

John A. Lust, MD, PhD, John E. Thompson, PhD, Catherine A. Taylor, PhD, Bin Ye, Zhongda Liu, Zhong Sun, Richard S. Dondero, PhD, Laurie L. Moon-Tasson, Michael P. Kline, PhD, Kathleen A. Donovan, PhD

Blood (2008) 112 (11): 249.

https://doi.org/10.1182/blood.V112.11.249.249

Published: 2008

Journal Articles

Monoclonal Gammopathy as a Determinant of Adverse Outcomes in Patients with Chronic Kidney Disease.

Colin A. Hutchison, MBChB, John Townend, MBChB, MD, Graham P. Mead, PhD, Katie Chandler, BSc, Jo Harper, BSc, Arthur R. Bradwell, MBChB, FRCP, FRCPath, Rosetta Zakeri, MBChB, Paul Cockwell, MBChB, PhD

Blood (2006) 108 (11): 5053.

https://doi.org/10.1182/blood.V108.11.5053.5053

Published: 2006

Journal Articles

Tumor Targeting, Dosimetry and Clinical Response Data for Lymphorad-131 (LR131; Iodine I-131 Labeled B-Lymphocyte Stimulator) in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma.

Andrew Belch, Alexander McEwan*, Joanne Hewitt*, Terence Riauka, Michael Stabin*, Aaron Brill*, Gilles Gallant, Lara Blake*, Jerry Klein

Blood (2004) 104 (11): 750.

https://doi.org/10.1182/blood.V104.11.750.750

Published: 2004

NARROW

rs2431697, a Polymorphism of Mir-146a, Is a Precozing Marker of Progression to Secondary Myelofibrosis: New Epigenetic Regulation of Jak/Stat3 Signaling

H3K27M/I Mutations Promote Context-Dependent Transformation in Acute Myeloid Leukemia with RUNX1 Alterations

Improving Hospice Referral: Application of Regret-Based Decision Modeling at End-of-Life Care

Gene Expression Profiling of Extramedullary Disease-Related Toward Identification of a Terminal Disease Pathway in Multiple Myeloma

A Targeted Functional Clone Tracking Assay for the Identification of Tumour Suppressor Genes in BCP- ALL Implicates the Transcription Factors FOXO3 and PRDM1

Prolonged Overall Survival with Pomalidomide and Dexamethasone in Myeloma Characterized with End Stage Disease.

Patterns of CNS Involvement in Relapsed and/or Refractory Multiple Myeloma.

Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Refractory Patient-Derived Multiple Myeloma Cells, Growing in a Novel Humanized Mouse MM Model

Virus-Associated Hemophagocytic Syndrome Contributes to Fatal Outcome In Critical Ill Patients with 2009 Influenza A (H1N1) Infection.

Loss of Chemokine Receptor Expression and Tetraspanins Is Correlated with Extramedullary Disease In Multiple Myeloma

Only Concomitant Presence of Cytogenetic Abnormalities in Randomly Sampled Bone Marrow and in MRI-Defined Focal Lesions Imparts Poor Prognosis and Is Associated with Gene Expression Profiling (GEP)-Based High-Risk Myeloma.

Preclinical Studies Using Polyethylenimine (PEI) Nanoparticles Complexed with Eukaryotic Translation Initiation Factor 5A (eIF5A) siRNA and eIF5A K50R Plasmid DNA Demonstrates Significant Anti-Myeloma Activity in Vitro and in Vivo

Monoclonal Gammopathy as a Determinant of Adverse Outcomes in Patients with Chronic Kidney Disease.

Tumor Targeting, Dosimetry and Clinical Response Data for Lymphorad-131 (LR131; Iodine I-131 Labeled B-Lymphocyte Stimulator) in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only